Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1AFAMELANOTIDE[1] Afamelanotide[1] Afamelanotide 💬[1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[2] 159, 254 💬
2Afamelanotide (16 mg implant)[1] Afamelanotide[1] Afamelanotide 💬[1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[1] 159 💬
3Ipilimumab[1] Ipilimumab[1] Ipilimumab 💬[1] CTLA4 💬[4] Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway 💬[1] 159 💬
4Isotretinoin[1] Isotretinoin[1] Isotretinoin 💬[2] RARA,
RARB 💬		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[4] 36, 39, 159, 160 💬
5Liposomal T4N5 lotion----[1] 159 💬
6Nivolumab[1] Nivolumab[1] Nivolumab 💬[1] PDCD1 💬[3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
7SCENESSE[1] Afamelanotide[1] Afamelanotide 💬[1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[3] 159, 161, 254 💬
8TRABECTEDINA[1] Trabectedin[1] Trabectedin 💬--[1] 159 💬
9Trabectedine----[1] 159 💬
10Yondelis[1] Trabectedin[1] Trabectedin 💬--[1] 159 💬
11YONDELIS 0,25 mg polvo para concentrado para solución para perfusión[1] Trabectedin[1] Trabectedin 💬--[1] 159 💬
12Yondelis 0.25 mg powder for concentrate for solution for infusion.[1] Trabectedin[1] Trabectedin 💬--[1] 159 💬
13YONDELIS 1 mg polvo para concentrado para solución para perfusión[1] Trabectedin[1] Trabectedin 💬--[1] 159 💬
14Yondelis 1 mg powder for concentrate for solution for infusion.[1] Trabectedin[1] Trabectedin 💬--[1] 159 💬